Bioavailability and bone toxicity of barium chloride administered continuously in rats;Biodisponibilite et toxicite osseuse du chlorure de baryum en administration chronique chez le rat

Annales Pharmaceutiques Francaises

Volumn 54, Issue 6, 1996, Pages 263-267

  Constant, Hélène ^a   De Calbiac, Pascale ^a   Vray, Christine ^a   Dürr, Françoise ^b   Aulagner, Gilles ^a  

^a Service Pharmaceutique   (France)

^b HÔPITAL DEBROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BARIUM CHLORIDE; SUPRAPUR; UNCLASSIFIED DRUG; BARIUM DERIVATIVE; CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE; BONE LEVEL; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CONTAMINATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; ANIMAL; BIOAVAILABILITY; DRUG EFFECT; METABOLISM; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMALS; BARIUM COMPOUNDS; BIOLOGICAL AVAILABILITY; BONE AND BONES; CHLORIDES; INJECTIONS, INTRAVENOUS; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030332035     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Hurley DL et Mac Mahon MM. Endocrin and Met Clin North America 1990 ; 19 : 1.
2. Arlot ME, Gerard M, Robert D. Bone status in total parenteral nutrition. In Osteoporosis C. Christiansen (Overgaard Ed.) 1990 ; 1719-20. Copenhague.
3. Tam CS and Jeejeebhoy KN. Bone changes in patients on total parenteral nutrition: follow up by sequential bone biopsie. In Metabolic bone disease in total parenteral nutrition, Coburn JW, Klein GL (Urban and Schwarzenberg Ed), 1985, Baltimore - Munich.
4. Bréant V, Aulagner G, Laffont-Mevel A, Fusselier M. Ann Pharmaceutiques françaises 1993 ; 51 : 273-82.
5. Newton D, Rundo J et Harrisson GE. Health Phys 1977 ; 33 : 45-53.
6. Liniecki J. Health Phys 1971 ; 27 : 367-376.
7. Castagnou MR, Lacerbau S, Paoletti MC. Bull Soc Pharm Bordeaux 1959 ; 98 : 25-33.
8. Castagnou MR, Lacerbau S, Paoletti MC. Bull Soc Pharm Bordeaux 1959 ; 98 : 34-41.
9. Fabre R, Truhaut R. Ann Pharmaceutiques françaises 1962 ; 20 : 505-22.
10. Labaume JP. Pharmacocinétique: principes fondamentaux. Masson ed, 1984, Paris.
11. ICRP International Commission on Radiological Protection. Radiation dose to patients from radiopharmaceuticals. ICRP publication 53, Pergamon Press, 1984, Oxford.
12. Mac Cauley PT, Washington IS. Drug Chem Toxicol 1983 ; 6 : 209-17.
13. Leblondel G, Mauras Y, Allain P. Biol Trace Elem Res 1986 ; 10 : 327-33.
14. Schroeder HA, Tipton IH, Nason AP. J Chronic Dis 1972 ; 25 : 491-517.
15. Taylor DM, Bligh PH, Duggan MH. Biochem J 1962 ; 83 : 25.